Fund shareholders of Ionis Pharmaceuticals Inc
ISIN US4622221004 · United States · LEI 549300SI4ZGLG0BLUZ92
- Fund shareholders
- 436
- Of which ETFs
- 100 336 other funds
- Value held
- 6.6B $ 346.9M SEK · 4M €
- Share of capital
- 51.7 % of 166.2M shares on Jul 23, 2026
436 funds hold this company. This table lists the 431 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 8,111,335 | 658.2M $ | 0.80 % | 4.88 % | as of Feb 28, 2026 ↗ |
| Growth Fund of America Growth Fund of America | 7,668,655 | 622.3M $ | 0.19 % | 4.61 % | as of Feb 28, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 4,995,141 | 375.1M $ | 0.02 % | 3.01 % | as of Mar 31, 2026 ↗ |
| New Economy Fund New Economy Fund | 4,723,802 | 383.3M $ | 0.85 % | 2.84 % | as of Feb 28, 2026 ↗ |
| SMALLCAP World Fund Inc SMALLCAP World Fund Inc | 4,458,145 | 334.8M $ | 0.41 % | 2.68 % | as of Mar 31, 2026 ↗ |
| VANGUARD HEALTH CARE FUND VANGUARD SPECIALIZED FUNDS | 3,803,181 | 284.3M $ | 0.77 % | 2.29 % | as of Apr 30, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 3,618,441 | 271.7M $ | 0.17 % | 2.18 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Mid-Cap Growth Fund, Inc. T. ROWE PRICE MID-CAP GROWTH FUND, INC. | 2,760,687 | 207.3M $ | 0.92 % | 1.66 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 2,315,503 | 187.9M $ | 0.81 % | 1.39 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 2,096,577 | 170.1M $ | 0.80 % | 1.26 % | as of Feb 28, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 2,025,434 | 152.1M $ | 0.39 % | 1.22 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,808,172 | 135.8M $ | 0.17 % | 1.09 % | as of Mar 31, 2026 ↗ |
| Tweedy, Browne International Value Fund Tweedy, Browne Fund Inc. | 1,743,125 | 130.9M $ | 3.17 % | 1.05 % | as of Mar 31, 2026 ↗ |
| Growth Fund AMERICAN FUNDS INSURANCE SERIES | 1,674,900 | 125.8M $ | 0.25 % | 1.01 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 1,205,549 | 90.5M $ | 1.11 % | 0.73 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 1,195,911 | 89.4M $ | 0.41 % | 0.72 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 1,132,906 | 85.1M $ | 1.14 % | 0.68 % | as of Mar 31, 2026 ↗ |
| Capital Group Growth ETF Capital Group Growth ETF | 1,054,074 | 85.5M $ | 0.42 % | 0.63 % | as of Feb 28, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 987,917 | 74.2M $ | 0.40 % | 0.59 % | as of Mar 31, 2026 ↗ |
| Select Fund American Century Mutual Funds, Inc. | 962,000 | 71.9M $ | 1.12 % | 0.58 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 882,823 | 66.3M $ | 0.61 % | 0.53 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 847,073 | 68.7M $ | 0.17 % | 0.51 % | as of Feb 28, 2026 ↗ |
| JPMorgan Mid Cap Growth Fund JPMorgan Trust II | 806,672 | 60.6M $ | 0.53 % | 0.49 % | as of Mar 31, 2026 ↗ |
| Franklin Dynatech Fund Franklin Custodian Funds | 800,000 | 60.1M $ | 0.24 % | 0.48 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 786,080 | 63.8M $ | 0.31 % | 0.47 % | as of Feb 28, 2026 ↗ |
| Nomura Mid Cap Growth Fund IVY FUNDS | 606,560 | 45.5M $ | 1.52 % | 0.36 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 603,764 | 45.3M $ | 0.09 % | 0.36 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 592,553 | 44.5M $ | 0.04 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 585,766 | 43.8M $ | 0.09 % | 0.35 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC. | 578,082 | 43.4M $ | 0.34 % | 0.35 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 575,000 | 43.2M $ | 2.72 % | 0.35 % | as of Mar 31, 2026 ↗ |
| JNL/T. Rowe Price Mid-Cap Growth Fund JNL Series Trust | 492,756 | 37M $ | 0.92 % | 0.30 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 476,377 | 38.7M $ | 0.72 % | 0.29 % | as of Feb 28, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 455,079 | 36.9M $ | 0.18 % | 0.27 % | as of Feb 28, 2026 ↗ |
| Schwab U.S. Mid-Cap ETF SCHWAB STRATEGIC TRUST | 438,078 | 35.6M $ | 0.26 % | 0.26 % | as of Feb 28, 2026 ↗ |
| Fidelity SAI Small-Mid Cap Momentum Index Fund Fidelity Salem Street Trust | 429,251 | 32.1M $ | 0.75 % | 0.26 % | as of Apr 30, 2026 ↗ |
| Artisan International Small-Mid Fund Artisan Partners Funds Inc. | 390,363 | 29.3M $ | 1.10 % | 0.23 % | as of Mar 31, 2026 ↗ |
| Global Growth Fund AMERICAN FUNDS INSURANCE SERIES | 388,000 | 29.1M $ | 0.34 % | 0.23 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 379,257 | 28.5M $ | 0.28 % | 0.23 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Institutional Mid-Cap Equity Growth Fund T. Rowe Price Equity Funds, Inc. | 334,595 | 25.1M $ | 0.91 % | 0.20 % | as of Mar 31, 2026 ↗ |
| Small Cap Growth Fund American Century Mutual Funds, Inc. | 311,872 | 23.3M $ | 0.46 % | 0.19 % | as of Apr 30, 2026 ↗ |
| MFS New Discovery Fund MFS SERIES TRUST I | 306,440 | 24.9M $ | 1.19 % | 0.18 % | as of Feb 28, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 304,119 | 24.7M $ | 0.02 % | 0.18 % | as of Feb 28, 2026 ↗ |
| ARK Genomic Revolution ETF ARK ETF Trust | 288,230 | 21.5M $ | 1.74 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Artisan Small Cap Fund Artisan Partners Funds Inc. | 280,144 | 21M $ | 2.36 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Capital Group U.S. Small and Mid Cap ETF Capital Group Equity ETF Trust I | 272,278 | 22.1M $ | 1.32 % | 0.16 % | as of Feb 28, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 269,755 | 21.9M $ | 0.02 % | 0.16 % | as of Feb 28, 2026 ↗ |
| MassMutual Mid Cap Growth Fund MASSMUTUAL SELECT FUNDS | 254,240 | 19.1M $ | 0.69 % | 0.15 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 242,155 | 19.7M $ | 0.04 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 240,112 | 19.5M $ | 0.02 % | 0.14 % | as of Feb 28, 2026 ↗ |
| Empower T. Rowe Price Mid Cap Growth Fund EMPOWER FUNDS, INC. | 239,848 | 18M $ | 0.95 % | 0.14 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 230,687 | 17.3M $ | 0.01 % | 0.14 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC. | 227,425 | 17.1M $ | 0.21 % | 0.14 % | as of Mar 31, 2026 ↗ |
| JNL/JPMorgan MidCap Growth Fund JNL Series Trust | 221,855 | 16.7M $ | 0.53 % | 0.13 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Diversified Mid-Cap Growth Fund, Inc. T. ROWE PRICE DIVERSIFIED MID-CAP GROWTH FUND, INC. | 221,400 | 16.6M $ | 0.39 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Invesco Main Street Mid Cap Fund AIM Growth Series (Invesco Growth Series) | 209,750 | 15.8M $ | 0.67 % | 0.13 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 208,977 | 15.6M $ | 0.04 % | 0.13 % | as of Apr 30, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 206,933 | 15.5M $ | 0.63 % | 0.12 % | as of Mar 31, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 206,338 | 15.5M $ | 0.02 % | 0.12 % | as of Mar 31, 2026 ↗ |
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 205,400 | 15.4M $ | 1.48 % | 0.12 % | as of Apr 30, 2026 ↗ |
| MFS New Discovery Value Fund MFS SERIES TRUST XIII | 204,801 | 16.6M $ | 0.61 % | 0.12 % | as of Feb 28, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 201,598 | 15.1M $ | 1.72 % | 0.12 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Small/Mid Cap Growth Fund Goldman Sachs Trust | 187,207 | 15.2M $ | 1.24 % | 0.11 % | as of Feb 28, 2026 ↗ |
| Artisan Mid Cap Fund Artisan Partners Funds Inc. | 186,456 | 14M $ | 0.47 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 179,499 | 13.5M $ | 0.40 % | 0.11 % | as of Mar 31, 2026 ↗ |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 170,008 | 13.8M $ | 0.21 % | 0.10 % | as of Feb 27, 2026 ↗ |
| Tweedy, Browne Value Fund Tweedy, Browne Fund Inc. | 169,635 | 12.7M $ | 2.79 % | 0.10 % | as of Mar 31, 2026 ↗ |
| JPMorgan Large Cap Value Fund JPMorgan Trust II | 168,569 | 12.7M $ | 0.26 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Franklin Small-Mid Cap Growth Fund Franklin Strategic Series | 167,060 | 12.5M $ | 0.35 % | 0.10 % | as of Apr 30, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 164,671 | 12.4M $ | 0.05 % | 0.10 % | as of Mar 31, 2026 ↗ |
| Handelsbanken Hälsovård Tema Handelsbanken Fonder AB | 154,000 | 110.2M SEK | 0.50 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Growth Fund Bridge Builder Trust | 153,612 | 11.5M $ | 0.12 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Invesco Small Cap Growth Fund AIM Growth Series (Invesco Growth Series) | 152,122 | 11.4M $ | 0.74 % | 0.09 % | as of Mar 31, 2026 ↗ |
| JNL/Invesco Small Cap Growth Fund JNL Series Trust | 150,988 | 11.3M $ | 0.73 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Nuveen ESG Small-Cap ETF NuShares ETF Trust | 150,398 | 11.2M $ | 0.87 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Columbia Acorn Fund COLUMBIA ACORN TRUST | 148,670 | 11.2M $ | 0.50 % | 0.09 % | as of Mar 31, 2026 ↗ |
| Invesco RAFI US 1500 Small-Mid ETF Invesco Exchange-Traded Fund Trust | 140,692 | 10.5M $ | 0.37 % | 0.08 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 138,602 | 10.4M $ | 0.01 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 129,890 | 9.7M $ | 0.02 % | 0.08 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Mid Cap Growth Portfolio Brighthouse Funds Trust I | 127,690 | 9.6M $ | 0.91 % | 0.08 % | as of Mar 31, 2026 ↗ |
| iShares U.S. Small-Cap Equity Factor ETF iShares Trust | 121,095 | 9.1M $ | 0.25 % | 0.07 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Equity Factor Rotation Active ETF BlackRock ETF Trust | 118,150 | 8.8M $ | 0.03 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Goldman Sachs Mid Cap Growth Fund Goldman Sachs Trust | 116,280 | 9.4M $ | 0.96 % | 0.07 % | as of Feb 28, 2026 ↗ |
| SEB Läkemedelsfond SEB Funds AB | 114,334 | 81.8M SEK | 0.51 % | 0.07 % | as of Mar 31, 2026 ↗ |
| JPMorgan Mid Cap Equity Fund JPMorgan Trust I | 111,845 | 8.4M $ | 0.15 % | 0.07 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 110,042 | 8.3M $ | 0.02 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Invesco Health Care Fund AIM Investment Funds (Invesco Investment Funds) | 107,312 | 8M $ | 0.71 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Fidelity SAI U.S. Momentum Index Fund Fidelity Salem Street Trust | 106,308 | 7.9M $ | 0.10 % | 0.06 % | as of Apr 30, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 102,433 | 7.7M $ | 0.56 % | 0.06 % | as of Mar 31, 2026 ↗ |
| AMG TimesSquare Mid Cap Growth Fund AMG Funds | 101,884 | 7.7M $ | 0.51 % | 0.06 % | as of Mar 31, 2026 ↗ |
| JPMorgan Active Value ETF J.P. Morgan Exchange-Traded Fund Trust | 101,151 | 7.6M $ | 0.13 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 97,359 | 7.3M $ | 0.02 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 96,289 | 7.8M $ | 0.03 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 95,438 | 7.1M $ | 0.02 % | 0.06 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 95,236 | 7.7M $ | 0.02 % | 0.06 % | as of Feb 28, 2026 ↗ |
| MFS New Discovery Series MFS VARIABLE INSURANCE TRUST | 94,701 | 7.1M $ | 1.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Mid Cap Growth Fund John Hancock Investment Trust | 94,101 | 7.1M $ | 0.62 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 90,571 | 6.8M $ | 0.04 % | 0.05 % | as of Apr 30, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 88,570 | 6.7M $ | 0.01 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Bridge Builder Small/Mid Cap Value Fund Bridge Builder Trust | 87,365 | 6.6M $ | 0.07 % | 0.05 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Horizon Kinetics Medical ETF Listed Funds Trust | 4.73 % | as of Mar 31, 2026 ↗ |
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 4.58 % | as of Dec 31, 2025 ↗ |
| HealthInvest Small & Mid Cap Healthcare Atle Fund Management AB | 3.98 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 3.74 % | as of Mar 31, 2026 ↗ |
| GESTION BOUTIQUE VI, FI GESTION BOUTIQUE VI / KALDI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 3.68 % | as of Dec 31, 2025 ↗ |
| Tweedy, Browne International Value Fund Tweedy, Browne Fund Inc. | 3.17 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 2.81 % | as of Mar 31, 2026 ↗ |
| Tweedy, Browne Value Fund Tweedy, Browne Fund Inc. | 2.79 % | as of Mar 31, 2026 ↗ |
| Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST | 2.72 % | as of Mar 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 2.49 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 422 | +29 | 85,444,539 | +5.7 % |
| 2026Q1 | 393 | +45 | 80,814,443 | +5.3 % |
| 2025Q4 | 348 | +62 | 76,715,982 | -3.1 % |
| 2025Q3 | 286 | +12 | 79,201,702 | -1.0 % |
| 2025Q2 | 274 | -12 | 79,971,398 | +0.1 % |
| 2025Q1 | 286 | -17 | 79,920,146 | +7.6 % |
| 2024Q4 | 303 | +4 | 74,303,125 | +10.4 % |
| 2024Q3 | 299 | -10 | 67,280,894 | +3.7 % |
| 2024Q2 | 309 | +10 | 64,888,088 | +5.0 % |
| 2024Q1 | 299 | +15 | 61,777,585 | -4.9 % |
| 2023Q4 | 284 | 64,944,400 |
Institutional managers
483 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 24,556,637 | 1.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 21,186,369 | 1.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,442,476 | 784.1M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 6,391,816 | 480M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 6,159,027 | 462.5K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 5,857,629 | 439.8M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,995,564 | 300M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,984,332 | 305.2M $ | as of Mar 31, 2026 |
| ROYAL BANK OF CANADA | 3,801,815 | 285.5M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,025,251 | 227.2K $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,363,567 | 171.4M $ | as of Mar 31, 2026 |
| Tweedy, Browne Co LLC | 2,275,625 | 170.9M $ | as of Mar 31, 2026 |
| Artisan Partners Limited Partnership | 2,058,308 | 154.6M $ | as of Mar 31, 2026 |
| BAKER BROS. ADVISORS LP | 2,047,727 | 153.8M $ | as of Mar 31, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 1,979,669 | 148.7M $ | as of Mar 31, 2026 |
| Deep Track Capital, LP | 1,950,000 | 146.4M $ | as of Mar 31, 2026 |
| Bellevue Group AG | 1,818,665 | 136.6M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,699,847 | 127.6M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,663,803 | 124.9M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,583,266 | 118.9M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 1,575,023 | 118.3M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,475,632 | 110.8M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 1,434,995 | 107.1M $ | as of Mar 31, 2026 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1,404,033 | 105.4M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,277,358 | 95.9M $ | as of Mar 31, 2026 |
Declared shareholders of Ionis Pharmaceuticals Inc
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Capital World Investors | 12.80 % | 21,186,369 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.05 % | 8,344,732 | as of Mar 31, 2026 · SCHEDULE 13G |
| T. Rowe Price Investment Management, Inc. | 3.70 % | 6,159,027 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Ionis Pharmaceuticals Inc
55 funds declare 74 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Ionis Pharmaceuticals Inc". https://titelia.com/en/stocks/ionis-pharmaceuticals-inc-US4622221004